Key facts
- This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Apr 2025, 21:30.
David Hung - 04 Apr 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)
- Reporting relationship
- PRESIDENT AND CEO, Director, 10%+ Owner
- Issuer ticker
- NUVB
- Reported as of
- 04 Apr 2025
- Net transaction value
- +$820,220
- SEC form
- 4
- Accepted by SEC
- 08 Apr 2025, 21:30:51 UTC
- Prior SEC filing
- 04 Mar 2025
- Next SEC filing
- 04 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Dang, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 08 Apr 2025.
Change
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: +$820,220.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUVB
transaction
Class A Common Stock
Purchase
- Transaction value
- $332,720
- Shares
- +200,000
- Change %
- +0.34%
- Price
- $1.66
- Shares after
- 58,481,054
- Date
- 04 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
NUVB
transaction
Class A Common Stock
Purchase
- Transaction value
- $487,500
- Shares
- +300,000
- Change %
- +0.51%
- Price
- $1.62
- Shares after
- 58,781,054
- Date
- 07 Apr 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Footnote F2
) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.